User profiles for C. C. Collins
Colin Collins, PhDProfessor of Urologic Sciences, University of British Columbia and Vancouver Prostate … Verified email at prostatecentre.com Cited by 34234 |
Vision substitution by tactile image projection
P Bach-y-Rita, CC Collins, FA Saunders, B White… - Nature, 1969 - nature.com
WE describe here a vision substitution system which is being developed as a practical aid
for the blind and as a means of studying the processing of afferent information in the central …
for the blind and as a means of studying the processing of afferent information in the central …
Cancer‐generated lactic acid: a regulatory, immunosuppressive metabolite?
SYC Choi, CC Collins, PW Gout… - The Journal of …, 2013 - Wiley Online Library
The common preference of cancers for lactic acid‐generating metabolic energy pathways
has led to proposals that their reprogrammed metabolism confers growth advantages such as …
has led to proposals that their reprogrammed metabolism confers growth advantages such as …
[HTML][HTML] Lessons from patient-derived xenografts for better in vitro modeling of human cancer
SYC Choi, D Lin, PW Gout, CC Collins, Y Xu… - Advanced drug delivery …, 2014 - Elsevier
The development of novel cancer therapeutics is often plagued by discrepancies between
drug efficacies obtained in preclinical studies and outcomes of clinical trials. The …
drug efficacies obtained in preclinical studies and outcomes of clinical trials. The …
Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1
…, ID Krantz, YU Deng, A Genin, AB Banta, CC Collins… - Nature …, 1997 - nature.com
… c, The proband and mother from family 3 demonstrate an HMA band shift in the "C" region.
SSCP analysis … c, No band shifts were observed on heteroduplex analysis with the A, B, …
SSCP analysis … c, No band shifts were observed on heteroduplex analysis with the A, B, …
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer that
most commonly evolves from preexisting prostate adenocarcinoma (PCA). Using next-…
most commonly evolves from preexisting prostate adenocarcinoma (PCA). Using next-…
[PDF][PDF] Pharmacologic weakening of extraocular muscles
…, A ROSENBAUM, CC COLLINS - … & Visual Science, 1973 - iovs.arvojournals.org
Currently, the correction of nonaccommodative strabismus involves surgical manipulation to
loosen or tighten extraocular muscles to balance the forces and align the eyes. The present …
loosen or tighten extraocular muscles to balance the forces and align the eyes. The present …
Genomic hallmarks of localized, non-indolent prostate cancer
Prostate tumours are highly variable in their response to therapies, but clinically available
prognostic factors can explain only a fraction of this heterogeneity. Here we analysed 200 …
prognostic factors can explain only a fraction of this heterogeneity. Here we analysed 200 …
[BOOK][B] Camillo Sitte: the birth of modern city planning
GR Collins, C Sitte, CC Collins - 2006 - books.google.com
… Collins and Christiane Crasemann Collins includes Sitte's original drawings and plates in
a format resembling the original publication. The authors place Sitte's work within the context …
a format resembling the original publication. The authors place Sitte's work within the context …
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically
localized, multifocal prostate cancer to delineate new oncogenes or tumor suppressors. We …
localized, multifocal prostate cancer to delineate new oncogenes or tumor suppressors. We …
Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer
Purpose: Although novel agents targeting the androgen–androgen receptor (AR) axis have
altered the treatment paradigm of metastatic castration-resistant prostate cancer (mCRPC), …
altered the treatment paradigm of metastatic castration-resistant prostate cancer (mCRPC), …